STK11 and cervical carcinoma: Indeed, our previous investigations demonstrated that AMPK activators could repress cervical cancer cell growth harboring with/without liver kinase B1 (LKB1) [33] by reducing AKT/FOXO3a/FOXM1 signaling [33,34] as well as DVL3/WNT/β-catenin signaling [35].